Vanguard Group’s Insight Molecular Diagnostics IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Buy |
|
|||||
|
2025
Q1 | $812K | Buy |
|
|||||
|
2024
Q4 | $576K | Sell |
|
|||||
|
2024
Q3 | $699K | Buy |
|
|||||
|
2024
Q2 | $721K | Sell |
|
|||||
|
2024
Q1 | $726K | Hold |
|
|||||
|
2023
Q4 | $620K | Buy |
|
|||||
|
2023
Q3 | $749K | Buy |
|
|||||
|
2023
Q2 | $1M | Hold |
|
|||||
|
2023
Q1 | $1.54M | Hold |
|
|||||
|
2022
Q4 | $1.4M | Buy |
|
|||||
|
2022
Q3 | $3.18M | Buy |
|
|||||
|
2022
Q2 | $3.91M | Buy |
|
|||||
|
2022
Q1 | $5.94M | Buy |
|
|||||
|
2021
Q4 | $8.45M | Buy |
|
|||||
|
2021
Q3 | $13.8M | Sell |
|
|||||
|
2021
Q2 | $22.4M | Buy |
|
|||||
|
2021
Q1 | $19.5M | Buy |
|
|||||
|
2020
Q4 | $6.47M | Buy |
|
|||||
|
2020
Q3 | $2.67M | Buy |
|
|||||
|
2020
Q2 | $3.46M | Buy |
|
|||||
|
2020
Q1 | $3.48M | Buy |
|
|||||
|
2019
Q4 | $2.93M | Sell |
|
|||||
|
2019
Q3 | $2.74M | Sell |
|
|||||
|
2019
Q2 | $3.52M | Buy |
|
|||||
|
2019
Q1 | $4.97M | Buy |
|
|||||
|
2018
Q4 | $470K | Sell |
|
|||||
|
2018
Q3 | $1.03M | Buy |
|
|||||
|
2018
Q2 | $1.01M | Buy |
|
|||||
|
2018
Q1 | $747K | Sell |
|
|||||
|
2017
Q4 | $1.66M | Buy |
|
|||||
|
2017
Q3 | $1.01M | Buy |
|
|||||
|
2017
Q2 | $565K | Buy |
|
|||||
|
2017
Q1 | $584K | Buy |
|
|||||
|
2016
Q4 | $683K | Buy |
|
|||||
|
2016
Q3 | $463K | Buy |
|
|||||
|
2016
Q2 | $317K | Sell |
|
|||||
|
2016
Q1 | $439K | Buy |
|